The NZM2410-derived Sle2 lupus susceptibility locus induces an abnormal B-cell differentiation, which most prominently leads to the expansion of autoreactive B1a cells. We have mapped the expansion of B1a cells to three Sle2 sub-loci, Sle2a, Sle2b and Sle2c. Sle2 also enhances the breach of B-cell tolerance to nuclear antigens in the 56R anti-DNA immunoglobulin transgenic (Tg) model. This study used the Sle2 sub-congenic strains to map the activation of 56R Tg B cells. Sle2c strongly sustained the breach of tolerance and the activation of anti-DNA B cells. The production of Tg-encoded anti-DNA antibodies was more modest in Sle2a-expressing mice, but Sle2a was responsible for the recruitment for Tg B cells to the marginal zone, a phenotype that has been found for 56R Tg B cells in mice expressing the whole Sle2 interval. In addition, Sle2a promoted the production of endogenously encoded anti-DNA antibodies. Overall, this study showed that at least two Sle2 genes are involved in the activation of anti-DNA B cells, and excluded more than two-thirds of the Sle2 interval from contributing to this phenotype. This constitutes an important step toward the identification of novel genes that have a critical role in B-cell tolerance.
Introduction
Sle2 is one of three major quantitative trait loci that increase susceptibility to lupus nephritis in the NZM2410 mouse model. 1 Analysis of congenic strains, combining these three loci on a C57BL/6 (B6) genetic background, has shown that Sle2 increased the frequency of fatal disease from 41% in B6.Sle1.Sle3 to 98% in B6.Sle1. Sle2.Sle3 mice.
2 Sle2 expression on a B6 background is associated with a number of B-cell defects, including an expansion of the B1a cell compartment, especially in the peritoneal cavity (PerC). Using congenic recombinants, we have determined that the expansion of B1a cells mapped to three sub-loci, Sle2a, Sle2b and Sle2c, with the major contribution provided by the telomeric Sle2c.
3 Sle2 also increased production of polyreactive immunoglobulin (Ig)M antibodies (Ab), 4 which may be at least in part related to the expansion of the B1a cell compartment.
The 56R Ig heavy chain (HC) transgenic (Tg) antinuclear autoreactive B cells represent one of the best characterized models of B-cell tolerance relevant to systemic lupus erythematosus. 5, 6 Autoreactive anti-nuclear specificities are created by pairing of the 56R HC (IgM a allotype) with a number of endogenous light chains. Contrary to the BALB/c genetic background, in which 56R Tg autoreactive B cells are effectively tolerized through, at a variety of checkpoints, the B6 background is more permissive, and induces the production of Tgencoded anti-DNA Abs. 7 The breach of tolerance by 56R Tg B cells is greatly enhanced by the MRL/lpr lupusprone genetic background. 6 Sle2 also enhances the activation and differentiation of 56R Tg autoreactive B cells; in these cells, B6.Sle2.56R mice produced significantly more Tg-encoded anti-DNA Abs than the B6.56R controls did. 8 Furthermore, the activation of autoreactive 56R Tg B cells by Sle2 involved their preferential recruitment to the marginal zone (MZ) compartment. 8 MZB cells in non-autoimmune mice are enriched for autoreactive specificities, 9 and preferential recruitment to this compartment might represent a mechanism by which autoreactive B cells escape tolerance checkpoints.
The present study was conducted to map the activation of 56R Tg B cells within the Sle2 locus using the subcongenic strains that were produced to map the expansion of B1a cells. 3 We have found that Sle2c, and to a lesser extent Sle2a, expression enhanced the breach of tolerance of anti-DNA 56R Tg cells. Furthermore, we found that Sle2a but not Sle2c promoted the recruitment of autoreactive B cells to the MZ. Finally, Sle2a induced the activation and differentiation of B cells, including autoreactive ones, expressing endogenous HCs. Overall, these results showed that at least two genes are involved in the Sle2 activation of anti-DNA autoreactive B cells, and excluded more than two-thirds of the Sle2 interval from contributing to this phenotype. This constitutes an important step toward the identification of novel genes that have a critical role in B-cell tolerance to nuclear antigens.
Results
Two Sle2 sub-loci enhanced Ab production from 56R Tg B cells Since their initial production and the characterization of their involvement in the accumulation of B1a cells, 3 the Sle2a and Sle2c intervals have been fine mapped ( Figure 1 ). Sle2a is now defined as a 1.5-4 Mb interval derived from the NZW portion of the NZM2410 genome, which contains a maximum of 24 expressed genes (Table 1) plus 16 additional predicted genes. The localization of Sle2c has been refined to a 10-15 Mb interval derived from the NZB portion of the NZM2410 genome, and it is has been renamed as Sle2c1 to distinguish it from a more telomeric locus, Sle2c2. 10 In this study, Sle2c1 will be referred to as Sle2c for simplicity. The Sle2b interval in the central part of Sle2 is the largest one, and it potentially overlaps with Sle2c in their respective telomeric and centromeric recombination regions.
Activation of autoreactive 56R Tg B cells was first assessed by the presence of serum anti-DNA IgM Abs in the three sub-congenic strains as compared with B6.56R. Samples from B6.Sle2.56R were used as positive controls. B6.Sle2a.56R and B6.Sle2c.56R produced significantly more anti-ssDNA IgM than B6.56R mice, whereas there was no difference between B6.Sle2b.56R and B6.56R (Figure 2a) . Interestingly, both B6.Sle2a.56R and B6.Sle2c.56R produced significantly more anti-ssDNA IgM than B6.Sle2.56R mice (P ¼ 0.006 and P ¼ 0.001, respectively), suggesting that Sle2 also contains a suppressive locus located outside the Sle2a and Sle2c regions. As expected, the majority anti-ssDNA IgM was of the Tg-encoded IgM a allotype in B6.Sle2.56R and B6.Sle2c.56R mice (Figure 2b ). This was not the case, however, for B6.Sle2a.56R mice, in which the majority of anti-ssDNA IgM Abs carried the endogenous IgM b allotype (Figure 2c ). Similar results were obtained for anti-dsDNA IgM (Figures 2d-f 
Epb4.1l4b Sle2a induced the recruitment 56R Tg B cells to the MZB compartment, and Sle2c increased their activation The effect of the Sle2 sub-loci expression on the distribution of peripheral B cells and their activation was analyzed by flow cytometry. A significantly higher ratio of PerC B1a versus B2 IgM a 56R Tg B cells was found in B6.Sle2.56R mice compared with B6.56R mice (Figure 4a ). The PerC B1a/B2 IgM a 56R Tg B-cell ratio was, however, similar between the three Sle2 sub-congenic strains and B6.56R. As expected, the proportion of endogenous PerC B cells with a B1a phenotype was much higher in B6.Sle2.56R than in B6.56R mice (Figure 4b ). This was also the case for both B6.Sle2a.56R and B6.Sle2c.56R, although to a lower level than with the full interval. This confirmed that the Sle2 sub-loci have additive effect to promote the recruitment of B cells into the B1a compartment, and that it also applied to Tg B cells.
All five 56R congenic strains showed similar splenocyte numbers (data not shown), percentages ( Figure 4c ) and numbers (data not shown) of B220 þ cells, as well as percentages (Figure 4d ) and numbers (data not shown) of IgM a Tg B cells (about 80% of the total B cells). The distribution of these splenic B cells differed, however, between strains. As previously reported, the MZB compartment was greatly expanded in the 56R strains ( Figure 4e , compare with non-Tg strains on the right of the graph), and this expansion was further enhanced by Sle2 expression. Both Sle2a and Sle2c expression expanded the MZB compartment in 56R Tg mice (Figure 4e ), but only Sle2a was associated with the expansion of the 56R Tg IgM a MZB subset that has been 8 Interestingly, in addition to be recruited more frequently to the MZ, total B220
þ IgM a Tg B cells were also larger in B6.Sle2a.56R IgM a than in the other 56R congenic strains (Figure 4g ). Finally, the increased activation of 56R Tg IgM a B cells that has been described for B6.Sle2.56R mice 8 mapped to Sle2c and not to Sle2a, as shown for both class II I-a b ( Figure 4h ) and CD86 ( Figure 4i ). As for Ab production, the B cells in B6.Sle2b.56R mice were very similar to that of B6.56R, except for an increased I-a b expression (Figure 4h ). This indicated that the Sle2b interval could be excluded from contributing toward the activation of autoreactive B cells.
The effects of Sle2a expression on the recruitment of the 56R Tg B cells to the MZ was examined by histology. We used CD1d expression to differentiate CDd1 hi MZB cells from CD1d lo follicular B cells, as this staining scheme has been validated in the NZM2410 model. 11 The MZ looked markedly expanded in size and cell density in B6.Sle2a.56R spleens as compared with either B6.56R or B6.Sle2c.56R (Figure 5a ). The B6.Sle2a.56R MZB cells were all from Tg origin, with no B6.Sle2a.56R IgM b cell being detected by histology in the MZ (data not shown). A morphometric analysis demonstrated that the MZ area contained significantly more B cells in B6.Sle2a.56R spleens than in either B6.56R or B6.Sle2c.56R spleens (Figure 5b ). The same result was obtained when the percentage of CD1d þ B cells was computed (Figure 5b) . We have previously shown that the majority of the MZB cells are located inside the follicles in NZM2410 and in B6.Sle1.Sle2.Sle3 mice. 11 This was not the case for B6.Sle2a.56R mice in which the majority of CD1d hi B cells were located inside the MZ, outside the Moma1 þ macrophages (Figures 5a and d) . Furthermore, the proportion of CD1d þ B cells that were located in the follicular was not different between 56R strains (data not 
Discussion
The mechanisms by which B-cell tolerance are maintained in normal individuals but breached in autoimmune conditions have been of a great interest to immunologists. Most of the studies have used B-cell receptor Tg mouse models, and a number of checkpoints have been defined from these studies. 6 The welldocumented effect of genetic background on the enforcement of these tolerance checkpoints implies that natural genetic variation regulates the fate of autoreactive B cells. Very little is known, however, on the identity of the genes that are involved. The lpr mutation that impairs Fas expression has been the first documented natural genetic variation that regulates B-cell tolerance. 12 Since then very little progress has been made with mouse models. In humans, progress has been made with recent association between the presence of autoAbs and loss-of-function rare variants of the sialic acid acetylesterase gene 13 or specific common alleles of the IRF7/PHRF1 locus. 14 We have used a congenic dissection approach to identify the genes responsible for lupus susceptibility in the NZM2410 model, 15 and we have identified two systemic lupus erythematosus-susceptibility loci, Sle1 and Sle2, that regulate B-cell tolerance. Within Sle1, Sle1b regulates B-cell tolerance to chromatin. 16 The double-Tg HEL model 17 has demonstrated that Sle1b impairs B-cell tolerance and differential expression of splice isoforms of . Each data point corresponds to a representative follicle from one mouse from the indicated strains. *Po0.05, **Po0.01 and ***Po0.001. A full colour version of this figure is available at the Genes and Immunity journal online.
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Ly108, a gene located in the Sle1b interval, were shown to regulate the deletion of autoreactive immature B cells. 18 These results have identified Ly108 as a novel gene that regulates B-cell tolerance to nuclear antigens. Sle2 affects B-cell development and functions in a B-cell intrinsic manner. 4, 19 Its involvement in B-cell tolerance was formally demonstrated with the 56H HC Tg model. 8 Therefore, the B6.Sle2.56R strain represents a good model to identify the genes in the Sle2 locus that amplify the breach of tolerance to nuclear antigens. We have already identified three regions in Sle2, Sle2a, Sle2b and Sle2c, which contribute to B1a cell expansion.
3 B1a cells are the major source of natural Abs and their repertoire is intrinsically autoreactive. 20 It is therefore possible that the same genetic variations regulate B1a cell numbers and B-cell tolerance. We have assessed Ab production, Bcell distribution and activation, and splenic histology to analyze the fate of B cells in B6.Sle2a.56R, B6.Sle2b.56R and B6.Sle2c.56R mice. These approaches concurred in identifying Sle2c and Sle2a as being responsible for the breach of tolerance of 56R Tg autoreactive B cells. The Sle2c interval induced the production of Tg-encoded anti-DNA Ab to a level similar or higher than the whole interval, as well as the activation of 56R Tg B cells. This identified Sle2c as the major contributor to B-cell breach of tolerance within Sle2. The interval that we used in this study is large (B24 Mb), with too many genes to consider as a candidate gene approach. We have produced Sle2c recombinants to map the B1a cell expansion, and identified a mutation in the promoter of the Cdkn2c gene that greatly reduces the expression of this cell cycle inhibitor and is associated by B1a cell expansion. 10 One may hypothesize that defects in cell cycle regulation may affect the fate of autoreactive B cells, as it has been shown for genes regulating apoptosis. 6 The Sle2c recombinants will be used to further map the activation of the 56R Tg B cells and determine whether it co-localizes with B1a cell expansion.
The involvement of Sle2a in 56R Tg B-cell activation and differentiation is more complex. The production of Tg-encoded anti-DNA Ab in Sle2a-expressing mice is intermediate between that of B6.Sle2c.56R and B6.56R mice. However, Sle2a is clearly the locus that drives the selection of the 56R Tg B cells to the MZB cell compartment. This MZB cell selection is not sufficient to recapitulate the entire Sle2 phenotype for 56R Tg B cells, indicating that once the autoreactive B cells are selected to the MZ, another step is necessary to fully activate them. B1a and MZB cells are functionally related and both are enriched for autoreactive specificities, 21 suggesting that the same gene might be responsible for the expansion of both the compartments. One can hypothesize that the presence of the 56R HC Tg polarizes the B-cell selection away from the B1a cell to the MZB cell compartment, but the molecular mechanism is the same. In addition, Sle2a was surprisingly associated with the differentiation of B cells, producing total and anti-DNA Ab-carrying endogenous HCs. Further experiments will be necessary to determine whether this phenotype results from early bone-marrow selection events or a differential peripheral expansion of Tg versus endogenous HC clones. It is not possible to determine at this point whether the two major Sle2a phenotypes, MZB expansion and preferential endogenous HC activation, are regulated by the same gene. None of the Sle2a genes represent an obvious candidate gene (Table 1) , and there are a large number of uncharacterized expressed sequences and predicted genes, indicating that a systematic approach will be necessary to identify the causative gene.
The Sle2b interval was associated with a modest contribution to the B1a cell expansion, 3 and we have shown here that it is not involved in the activation of anti-nuclear autoreactive B cells. This region is of interest because it contains the Ifna gene cluster, and we have shown that lower expression of type 1 interferons in B6.Sle2 mice was associated with increased autoAb levels and B1a cell numbers. 22 Our results with the 56R Tg model indicate that this is unrelated to the activation of anti-nuclear autoreactive B cells.
Overall, we have determined that at least two genes are responsible for the Sle2 activation of anti-nuclear autoreactive B cells and have greatly reduced the genomic location of these two genes to a third of the original whole interval. None of the genes located in either of the two loci have a known involvement in B-cell tolerance, which ensures that this study will lead to the discovery of new mechanisms of B-cell tolerance.
Materials and methods

Mice
The B6.Sle2 and B6.Sle2 sub-congenic strains have been previously described. 3, 15 The termini of the Sle2a and Sle2c1 intervals were mapped with a panel of singlenucleotide polymorphisms that are polymorphic between NZW and B6, and NZB and B6, respectively ( Figure 1) . Genotyping of single-nucleotide polymorphism was performed by direct sequencing. B6 mice were originally obtained from the Jackson Laboratories (Bar Harbor, ME, USA). B6.Sle2.56R and B6.56R breeders were obtained from Dr Chandra Mohan (UTSW, Dallas, TX, USA). B6.Sle2a.56R, B6.Sle2b.56R and B6.Sle2c.56R were produced by intercrossing the corresponding B6.Sle2 sub-congenic strains with B6.56R, and by selecting for homozygozity at the termini shown in Figure 1 and the presence of the 56R HC Tg as previously reported. 23 Mice used in this study were males and females aged between 9 and 12 months of age. All experiments were conducted according to protocols approved by the University of Florida Institutional Animal Care and Use Committee.
Antibody measurements
Total IgM and IgG was measured as previously described. 24 Total IgM a or IgM b was detected in plates coated with goat anti-k and revealed by polyclonal rabbit anti-IgM a or IgM b (Accurate Chemical & Scientific Corp., Westbury, NY, USA), followed by goat anti-rabbit-AP (Sigma-Aldrich, St Louis, MO, USA). Anti-ssDNA and dsDNA IgM, IgM a or IgM b were detected in the same manner on plates coated with dsDNA or heat-denatured ssDNA (50 mg ml À1 ) as previously described. 25 . In vitro Ab secretion was measured from magnetic bead-purified CD43 À B cells (10 5 per well), cultured in complete RPMI 1640 (Cellgro, Manassas, VA, USA), containing 10% fetal calf serum, with or without 5 mg ml À1 lipopolysaccharide (Sigma) for 5 days. Ab levels were measured by enzyme-
